Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ovarian Neoplasms

Free Subscription 15.08.2022 2 Anticancer Drugs 2 Br J Cancer 1 Clin Med Insights Oncol 1 Gynecol Oncol 1 Histopathology 1 Int J Cancer 1 Int J Oncol 1 J Clin Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Drugs

1. SHAN Y, Zhang B, Chen L, Zhang H, et al
   Herpesvirus entry mediator regulates the transduction of Tregs via STAT5/Foxp3 signaling pathway in ovarian cancer cells.
   Anticancer Drugs. 2022 Aug 9. pii: 00001813-990000000-00021.
   PubMed         Abstract available
   
   
2. ZHANG X, Hong S, Yang J, Liu J, et al
   Purvalanol A induces apoptosis and reverses cisplatin resistance in ovarian cancer.
   Anticancer Drugs. 2022 Aug 9. pii: 00001813-990000000-00018.
   PubMed         Abstract available
   
   

   
   Br J Cancer

3. GAHLAWAT AW, Witte T, Haarhuis L, Schott S, et al
   A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosis.
   Br J Cancer. 2022 Aug 5. pii: 10.1038/s41416-022-01925.
   PubMed         Abstract available
   
   
4. KOIZUME S, Takahashi T, Nakamura Y, Yoshihara M, et al
   Lipophagy-ICAM-1 pathway associated with fatty acid and oxygen deficiencies is involved in poor prognoses of ovarian clear cell carcinoma.
   Br J Cancer. 2022 Apr 21. pii: 10.1038/s41416-022-01808.
   PubMed         Abstract available
   
   

   
   Clin Med Insights Oncol

5. BARVE M, Aaron P, Manning L, Bognar E, et al
   Pilot Study of Combination Gemogenovatucel-T (Vigil) and Durvalumab in Women With Relapsed BRCA-wt Triple-Negative Breast or Ovarian Cancer.
   Clin Med Insights Oncol. 2022;16:11795549221110501.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

6. KUMAR A, Wang C, Sheedy SP, McCauley BM, et al
   Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer.
   Gynecol Oncol. 2022 Aug 2. pii: S0090-8258(22)00492.
   PubMed         Abstract available
   
   

   
   Histopathology

7. BENNETT JA, Oliva E
   The complex and often confusing history, histology and histogenesis of mesonephric, STK11 adnexal tumour and mesonephric-like neoplasms of the upper female genital tract (including broad ligament).
   Histopathology. 2022;81:280-296.
   PubMed         Abstract available
   
   

   
   Int J Cancer

8. SA JK, Kim J, Kang S, Kim SW, et al
   Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing; A Korean Gynecologic Oncology Group study (KGOG 3047).
   Int J Cancer. 2022 Jun 6. doi: 10.1002/ijc.34150.
   PubMed         Abstract available
   
   

   
   Int J Oncol

9. WANG Y, Han A, Chen E, Singh RK, et al
   [Corrigendum] The cranberry flavonoids PAC DP9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells.
   Int J Oncol. 2022;61.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

10. FU S, Corr BR, Culm-Merdek K, Mockbee C, et al
    Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer.
    J Clin Oncol. 2022;40:2568-2577.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: